Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1 Kuchena >99.0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Ruifu Chemical Supply Olmesartan Medoxomil Inopindirana Nemhando yepamusoro:
4,5-Dimethyl-1,3-Dioxol-2-One (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Ethyl 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Acid CAS 761404-85-7
N2-Trityl Olmesartan Acid CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Chemical Name | Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate |
Mashoko anoreva zvakafanana | Diethyl 2-PropylImidazoledicarbonate;2-Propyl-1H-Imidazole-4,5-Dicarboxylic Acid Diethyl Ester;2-Propylimidazoledicarboxylic Acid Diethyl Ester |
Nhamba yeCAS | 144689-94-1 |
Nhamba yeCAT | RF-PI1872 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C12H18N2O4 |
Molecular Weight | 254.29 |
Density | 1.160±0.06 g/cm3 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Yero Yero kusvika kuOff-White Powder |
Kuchena / Analysis Method | >99.0% (HPLC) |
Melting Point | 83.0~88.0℃ |
Zvemumvura (KF) | <0.50% |
Residue paIgnition | <0.20% |
Maximum Single Kusachena | <0.50% |
Zvose Zvisina Kuchena | <1.00% |
Proton NMR Spectrum | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Usage | Pakati peOlmesartan Medoxomil (CAS: 144689-63-4) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Diethyl 2-Propyl-1H-Imidazole-4,5-Dicarboxylate (CAS: 144689-94-1) iri pakati pekubatanidzwa kweOlmesartan Medoxomil (CAS: 144689-63-4).Olmesartan Medoxomil inoratidzirwa pakurapa kweBP (hypertension).Kuderedza high blood pressure kunobatsira kudzivirira sitiroko, heart attack, uye matambudziko eitsvo.Olmesartan ndeyekirasi yemishonga inonzi angiotensin receptor blockers (ARBs).Olmesartan inoshanda nekuzorodza tsinga dzeropa kuitira kuti ropa rifambe zviri nyore.Inogona kushandiswa yoga kana kusanganiswa nemamwe antihypertensive agents.Iyo US Chikafu neDrug Administration (FDA) yakaona kuti mabhenefiti eBenicar arambe achipfuura njodzi dzinogona kuitika kana ichishandiswa kurapa varwere vane high blood pressure maererano neiyo drug label.